No Data
Recent Uptick Might Appease RemeGen Co., Ltd. (HKG:9995) Institutional Owners After Losing 67% Over the Past Year
REMEGEN: 2024 Interim Report
Market Chatter: RemeGen Denies Rumors of Mass Layoffs; Shares Up 4%
Significant layoffs? Remegen responds: It is a normal business optimization. The recently adapted indication for Taitsip will be applied for listing.
①Regarding the online rumors of layoffs, the secretary of the board of directors of Remegen stated that the company has been sorting out its business since last year, and the optimization of positions and personnel is based on work needs, without a rigid proportion; ②The other party revealed that the severe myasthenia gravis indication of the targeted drug Taituxip is expected to apply for market approval soon. However, Taituxip is facing multiple competitions in the market.
Hong Kong stocks closed (09.16) | The Hang Seng Index rose 0.31%, and shares of innovative drug concept stocks led the gains. Yimingang Corporation (01541) doubled in value in three days.
Affected by multiple bearish news over the weekend, the Hong Kong stock market opened lower in the morning, but then maintained a volatile rise throughout the day. As of the close, the Hang Seng Index rose by 0.31% or 53.03 points, to 17422.12 points.
Hong Kong stock market abnormality | Remegen (09995) fell more than 20% intraday, second-quarter net loss significantly higher than expected, institutions lowered product peak sales.
Remegen (09995) fell more than 20% intraday. As of the time of writing, it has fallen by 14.57% to HKD 11.02, with a turnover of 20.0647 million Hong Kong dollars.
No Data
No Data